Shuttle Pharmaceuticals Holdings Management
Management criteria checks 3/4
Shuttle Pharmaceuticals Holdings' CEO is Anatoly Dritschilo, appointed in Dec 2012, has a tenure of 11.42 years. total yearly compensation is $399.18K, comprised of 71.9% salary and 28.1% bonuses, including company stock and options. directly owns 25.54% of the company’s shares, worth $1.84M. The average tenure of the management team and the board of directors is 11.4 years and 7.3 years respectively.
Key information
Anatoly Dritschilo
Chief executive officer
US$399.2k
Total compensation
| CEO salary percentage | 71.9% |
| CEO tenure | 11.4yrs |
| CEO ownership | 25.5% |
| Management average tenure | 11.4yrs |
| Board average tenure | 7.3yrs |
Recent management updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$399k | US$287k | -US$7m |
| Sep 30 2023 | n/a | n/a | -US$6m |
| Jun 30 2023 | n/a | n/a | -US$5m |
| Mar 31 2023 | n/a | n/a | -US$3m |
| Dec 31 2022 | US$269k | US$97k | -US$3m |
| Sep 30 2022 | n/a | n/a | -US$3m |
| Jun 30 2022 | n/a | n/a | -US$2m |
| Mar 31 2022 | n/a | n/a | -US$2m |
| Dec 31 2021 | US$190k | US$19k | -US$1m |
| Dec 31 2020 | US$35k | US$35k | -US$909k |
Compensation vs Market: Anatoly's total compensation ($USD399.18K) is below average for companies of similar size in the US market ($USD667.63K).
Compensation vs Earnings: Anatoly's compensation has increased whilst the company is unprofitable.
CEO
Anatoly Dritschilo (79 yo)
11.4yrs
Tenure
US$399,175
Compensation
Dr. Anatoly Dritschilo, M.D. serves as Member of Advisory Board of RetinalGeniX Technologies Inc since December 2023. He co-founded Shuttle Pharmaceuticals Holdings, Inc. since its formation in December 20...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 11.4yrs | US$399.18k | 25.54% $ 1.8m | |
| President & COO | 11.4yrs | US$314.01k | 0.039% $ 2.8k | |
| Co-Founder & Director | 11.4yrs | no data | 6.42% $ 463.5k | |
| CFO and VP of Operations & Regulatory | 4.8yrs | US$302.53k | 0.62% $ 44.7k | |
| Chief Clinical Officer & Chief Medical Officer | no data | US$263.23k | 0.014% $ 1.0k | |
| Co-Founder & Chief Scientific Officer for Biology | 11.4yrs | no data | 6.38% $ 460.7k | |
| General Counsel | no data | no data | 2.13% $ 153.5k |
11.4yrs
Average Tenure
68.5yo
Average Age
Experienced Management: SHPH's management team is seasoned and experienced (11.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 11.4yrs | US$399.18k | 25.54% $ 1.8m | |
| Co-Founder & Director | 11.4yrs | no data | 6.42% $ 463.5k | |
| Chairman of Scientific Advisory Committee | 6.3yrs | US$93.70k | no data | |
| Member of Scientific Advisory Committee | 11.3yrs | no data | no data | |
| Independent Director | 11.4yrs | no data | 0.010% $ 733.7 | |
| Member of Scientific Advisory Committee | 7.3yrs | no data | no data | |
| Independent Director | 5yrs | no data | 0.010% $ 733.7 | |
| Independent Director | 3.3yrs | no data | 0.017% $ 1.2k | |
| Member of Scientific Advisory Committee | 3.3yrs | no data | no data | |
| Member of Scientific Advisory Committee | 7.3yrs | no data | no data | |
| Independent Director | 1.6yrs | no data | 0.091% $ 6.5k |
7.3yrs
Average Tenure
65yo
Average Age
Experienced Board: SHPH's board of directors are considered experienced (7.3 years average tenure).